SOURCE: Wall Street Equity Research

Wall Street Equity Research

September 02, 2010 08:52 ET

Professional Research on Perrigo and NBTY -- The Exception Defying the Trend in the Healthcare Sector

JOHANNESBURG, SOUTH AFRICA--(Marketwire - September 2, 2010) -  www.wallstreetequityresearch.com gives shareholders valuable insight on drug related products stocks Perrigo Co. (NASDAQ: PRGO) and NBTY Inc. (NYSE: NTY). Sign up today at www.wallstreetequityresearch.com to receive free research reports on these equities.

The drug related products industry has been doing well so far this year, proving to be more recession proof than many other industries. Those offering generic alternatives to more expensive brand named products fared especially well, as consumers remain financially insecure. With patents for many large brand named products set to expire within the year, generic producers will be looking to increase their range of products.

www.wallstreetequityresearch.com is a specialized website where investors can have specific access to free reports drug related products industry; traders looking for analyst opinions on Perrigo Co., NBTY Inc. and other companies in this industry are welcomed to sign up for a free one year membership at http://www.wallstreetequityresearch.com/.

Some companies are releasing new products and expanding their portfolios in a bid to pick up more of the market share. Collaborations and acquisitions hold promise of great potential, as the expertise of one company is teamed with the wide ranging distribution of another. Companies are also looking to extend their geographical portfolios as emerging markets open up. Stronger demand from the developing world has sent many companies scrambling to capitalize. Visit us at http://www.wallstreetequityresearch.com/ to understand the catalysts and forces driving or affecting the drug related products industry in today's economic environment.

While the industry is doing well, recent recalls related to concerns about contamination and improper labeling have made the FDA increasingly overbearing. Companies are concerned that closer scrutiny by the FDA may increase production costs. Two companies affected by those are Perrigo Co. and NBTY Inc. even if at this moment in time they are performing quite well. Traders can get direct and free access to today's full reports on Perrigo Co. and NBTY Inc. by signing up at http://wallstreetequityresearch.com/September022010PerrigoCo.(PRGO)020910.php and http://wallstreetequityresearch.com/September022010NBTYInc.(NTY)020910.php.

About Wall Street Equity Research:

Wall Street Equity Research looks to bring simplicity and highly sophisticated research to an ever-changing investing environment. Wall Street Equity Research has been partnering with a number of North American and Emerging Economies analysts to bring you the best of both continents in terms of market analysis and analytical opinions. 

Contact Information